Emerald Clinical Guides Sponsor with Limited ClinicalTrial Experience in Phase II Melanoma-TIL Trial
Proactive identification of issues potentially affecting trial outcome led Emerald Clinical to…
Filter Clear
KOLs in 26 countries exceed expectations with proven strategies and communication network
Extraordinary achievements under unprecedented conditions due to established global relationships and unflinching…
Study helps yield full approval for investigative product by FDA for IgAN…
At the peak of the COVID pandemic, recruitment was met, and patient…
Early risk identification and comprehensive quality management plan ensured best possible outcome.
Collaborative teamwork results in success for this study involving rare indication in…